
|Articles|August 1, 2004
New Products & Services
Arlington Heights, IL-Presutti Laboratories has received FDA approval to market tinidazole (Tindamax) for the treatment of trichomoniasis, as well as giardiases, intestinal amebiases, and amebic liver abscess.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: MDT for Oligometastatic Prostate Cancer, with Chad Tang, MD
2
Study suggests potential diuretic effect with nadofaragene firadenovec
3
Praful Ravi, MB, BChir, MRCP, on PSMA-PET during initial systemic therapy for mHSPC
4
Clint Bahler, MD, reflects on precision medicine and focal therapy highlights at AUA 2026
5











